Cotización Amneal Pharmaceuticals - AMRX

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

8.07

Postura de Compra

8.07

Postura de Venta

8.26

Volume Operado de la Acción

1,276,844

7.69 Rango del Día 8.18

5.01 Rango de 52 semanas 9.475

Capitalización de Mercado [m]

2.5B

Precio Anterior

7.75

Precio de Apertura

7.74

Hora

8.0706

Última hora de negociación

Volumen financiero

US$ 10,298,737

Precio Promedio Ponderado

8.0658

Volumen promedio (3 m)

1,034,257

Acciones en circulación

309,844,430

Rendimiento del Dividendo

Ratio Precio/Utilidad

-21.65

Beneficio por acción (BPA)

-0.27

turnover

2.41B

Beneficio neto

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.amneal.com

Sede

Wilmington, Delaware, USA

Fundado

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was US$7.75. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of US$ 5.01 to US$ 9.475.

Amneal Pharmaceuticals currently has 309,844,430 shares in issue. The market capitalisation of Amneal Pharmaceuticals is US$2.40 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.65.

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in developing GLP-1 injectables Amneal...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	8.07	8.33	7.68	803147	7.93993838	CS
4	-0.2	-2.41837968561	8.27	8.9	7.68	1067201	8.35347155	CS
12	-0.45	-5.28169014085	8.52	9.475	7.52	1034257	8.51937607	CS
26	1.22	17.8102189781	6.85	9.475	6.29	1252219	7.91645198	CS
52	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS
156	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS
260	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1B
GOEVCanoo Inc	US$ 0.118 (7.08%)	382.65M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	251.71M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	221.41M